RxDoctor Payments Data

Akuwa Gbogbotsi

Family · Newark, NJNPI 1518576206

Payments from drug & device makers

$501in general payments, 2019–2025

Across 18 payments — averaging $27.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$253
  • Bayer$122
  • Merck$30
  • Sanofi-aventis U.S. LLC$24
  • Sanofi Pasteur Inc.$24
  • Phadia US Inc.$20
  • plus $28 from 2 others

What the payments were for

  • Food & beverage$501100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen(2 entities)10$253
Bayer1$122
Merck2$30
Sanofi-aventis U.S. LLC1$24
Sanofi Pasteur Inc.1$24
Phadia US Inc.1$20
GSK1$15
Sobi, Inc1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$501 in reported general payments places this provider in the 60th percentile of 2,692 family providers in New Jersey.

See all family providers in New Jersey

Medicare billing

Part B allowed, 2024
$1,715
Medicare patients
13
Services billed
19

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Albuterol Sulfate HfaAlbuterol Sulfate68$1,409
Atorvastatin Calcium122$1,349
Diclofenac Sodium30$908
Nifedipine ErNifedipine35$643
Montelukast Sodium32$641
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide26$484
Metformin Hcl60$471
Omeprazole30$433
Gabapentin40$382
Rosuvastatin Calcium20$299
Amlodipine Besylate57$293
Tamsulosin Hcl17$282
Metoprolol Succinate25$277
Losartan Potassium41$273
Lisinopril46$204

Paid to pharmacies, not to this prescriber.

Other family in Newark

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →